Table 2.
Markers with Predictive or Prognostic Value for SAP-Associated Cardiac Injury
Symbols | Sample Size | Clinical Implication | P value | References |
---|---|---|---|---|
Antiendotoxin core antibody | 45 | Assess the severity of acute pancreatitis (edematous/necrotic) | P < 0.05 | [139] |
33 | Identify patients with SAP complicated with MOF | P < 0.01 | [140] | |
20 | Predict poor outcome in patients with AP | P < 0.01 | [141] | |
HMGB1 | 80 | Determine the intestinal barrier dysfunction and infection in SAP | P < 0.01 | [143] |
sST2 | 295 | Predict mortality in myocardial infarction patients | P = 0.048 | [145 |
PAP | 98 | To be an indicator of the course of AP | P < 0.001 | [147] |
70 | To be a prognostic marker for disease severity in heart failure | P < 0.001 | [148] | |
sTREM-1 | 48 | Correlated with disease severity and early organ dysfunction in patients with AP | P < 0.01 | [149] |
838 | Associated with all-cause mortality and major adverse cardiovascular event | P < 0.001 | [150] | |
Heart rate variability | 41 | A good predictor of SAP complicated with IPN and multiple organ dysfunction | P < 0.01 | [153] |